GL1X · GenesisL1 explorer

Research workbench

A SARS-cov-2 neutralizing antibody

Analyse A SARS-cov-2 neutralizing antibody in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7F0X
Type
protein
Length
411 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike protein S1; Antibody
UniProt
P0DTC2
Pockets
4 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 9% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike protein S1protein18316% helix, 29% strandP0DTC2
BAntibodyprotein2284% helix, 49% strand—

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11780.510.7824empty
2830.350.7517empty
3660.340.7717empty
4610.300.7412empty

Interfaces

1 interface between chains.

  • A–B · 598 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 7F0X · A SARS-CoV-2 neutralizing antibody · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.